Genmab A/S (GMXAY.PK)

Trade GMXAY.PK now with
8/31/2018 8:36:07 AM Genmab Announces European Marketing Authorization For DARZALEX For Front Line Multiple Myeloma
8/8/2018 11:04:21 AM Genmab H1 Operating Income DKK 459 Mln Vs. DKK 582 Mln Prior Year
7/27/2018 8:30:57 AM Genmab : CHMP Issues Positive Opinion Recommending DARZALEX For Front Line Multiple Myeloma
7/17/2018 6:51:11 AM Genmab Q2 Net Sales Of DARZALEX $511 Mln; To Receive Royalties On Worldwide Net Sales From Janssen Biotech
7/12/2018 1:58:07 AM Genmab Enters Strategic Partnership With Immatics To Develop Next Generation Bispecific Cancer Immunotherapies
6/29/2018 10:22:26 AM Genmab To Pay Seattle Genetics Milestone Payment Of $7 Mln Under Antibody-Drug Conjugate Program Targeting AXL
4/17/2018 6:49:04 AM Genmab Reports Q1 Net Sales Of DARZALEX Totaled $432 Mln
1/23/2018 6:53:30 AM Genmab: Worldwide Net Sales Of DARZALEX (daratumumab) As Reported By Johnson & Johnson $1.242 Bln In 2017
1/22/2018 2:09:32 AM Genmab: Novartis’ Intends To Transition Arzerra (ofatumumab) From Commercial Availability To Limited Availability